TY - JOUR
AU - D. B. Fuller
AU - J. Gryczynski
AU - R. P. Schwartz
AU - C. Halsted
AU - S. G. Mitchell
AU - M. Whitter
A1 - 
AD - National Association of State Alcohol & Drug Abuse Directors, Inc., 1919 Pennsylvania Avenue, NW, Suite M-250, Washington, DC 20006, United States of America. Electronic address: dfuller@nasadad.org.; Friends Research Institute, Inc., 1040 Park Avenue, #103, Baltimore, MD 21201, United States of America. Electronic address: jgryczynski@friendsresearch.org.; Friends Research Institute, Inc., 1040 Park Avenue, #103, Baltimore, MD 21201, United States of America. Electronic address: rschwartz@friendsresearch.org.; National Association of State Alcohol & Drug Abuse Directors, Inc., 1919 Pennsylvania Avenue, NW, Suite M-250, Washington, DC 20006, United States of America. Electronic address: chalsted@nasadad.org.; Friends Research Institute, Inc., 1040 Park Avenue, #103, Baltimore, MD 21201, United States of America. Electronic address: smitchell@friendsresearch.org.; National Association of State Alcohol & Drug Abuse Directors, Inc., 1919 Pennsylvania Avenue, NW, Suite M-250, Washington, DC 20006, United States of America. Electronic address: mwhitter@nasadad.org.
AN - 38042301
BT - J Subst Use Addict Treat
C5 - Opioids & Substance Use; HIT & Telehealth; Education & Workforce; Healthcare Policy
DA - Mar
DO - 10.1016/j.josat.2023.209214
DP - NLM
ET - 20231130
JF - J Subst Use Addict Treat
PY - 2024
SN - 2949-8767 (Print); 2949-8759
SP - 209214
ST - State guidance and system changes related to COVID-19: Impact on opioid treatment programs
T1 - State guidance and system changes related to COVID-19: Impact on opioid treatment programs
T2 - J Subst Use Addict Treat
TI - State guidance and system changes related to COVID-19: Impact on opioid treatment programs
U1 - Opioids & Substance Use; HIT & Telehealth; Education & Workforce; Healthcare Policy
U3 - 10.1016/j.josat.2023.209214
VL - 158
VO - 2949-8767 (Print); 2949-8759
Y1 - 2024
ER -